Spire Wealth Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Spire Wealth Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-290	Closed	-$4.36K	–	2461
2025 Q2	$4.36K	Hold	290	–	–	﹤0.01%	1988
2025 Q1	$3.83K	Sell	290 -375	-56%	-$5.17K	﹤0.01%	2130
2024 Q4	$10.5K	Hold	665	–	–	﹤0.01%	1816
2024 Q3	$10.6K	Hold	665	–	–	﹤0.01%	1611
2024 Q2	$10.1K	Hold	665	–	–	﹤0.01%	1628
2024 Q1	$9.76K	Hold	665	–	–	﹤0.01%	1717
2023 Q4	$9.03K	Buy	665 +290	+77%	+$3.88K	﹤0.01%	1787
2023 Q3	$5.01K	Buy	375 +250	+200%	+$3.38K	﹤0.01%	1941
2023 Q2	$1.58K	Hold	125	–	–	﹤0.01%	2234
2023 Q1	$1.42K	Hold	125	–	–	﹤0.01%	2331
2022 Q4	$1K	Hold	125	–	–	﹤0.01%	2233
2022 Q3	$1K	Buy	+125	New	+$1.33K	﹤0.01%	2124
2022 Q1	–	Sell	-2,950	Closed	-$39K	–	2808
2021 Q4	$39K	Buy	+2,950	New	+$37.2K	﹤0.01%	1835
2021 Q2	–	Sell	-5,900	Closed	-$72K	–	2896
2021 Q1	$72K	Buy	+5,900	New	+$75.8K	﹤0.01%	1545

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Spire Wealth Management's RDY Position: Q3 2025 in Review

Spire Wealth Management sold out of Dr. Reddy's Laboratories (RDY) in Q3 2025, closing a stake of 290 shares — an estimated $4.36K sold.

Spire Wealth Management first reported a position in RDY in Q1 2021 and held it in 14 quarters. The position peaked at $72K in Q1 2021. 228 funds tracked by Wall St. Rank hold RDY as of Q3 2025.

Spire Wealth Management reported no remaining Dr. Reddy's Laboratories position as of Q3 2025 after selling out during the quarter.
Spire Wealth Management sold 290 Dr. Reddy's Laboratories shares in Q3 2025, an estimated $4.36K.
Spire Wealth Management first reported a position in Dr. Reddy's Laboratories in Q1 2021 and held it in 14 quarters.
Spire Wealth Management's Dr. Reddy's Laboratories position peaked at $72K in Q1 2021.
228 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2025.

Based on Spire Wealth Management's 13F filing for Q3 2025, filed 23 Oct 2025.